Keywords: Eli Lilly, Financial guidance, Revenue and earnings forecasts

Eli Lilly financial guidance beats expectations

Article | 07 January 2013

Print This

Shares of US drug major Eli Lilly (NYSE: LLY) ended Friday up nearly 4% at $51.56, after the company announced better-than-expected financial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in